Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1331 of 5804
-
What happens when you stop Weight-Loss shots? new study tests backup plans
Disease control CompletedThe study compares the effectiveness of treatment options for weight management after discontinuing semaglutide and tirzepatide. The primary outcome is absolute and percentage weight change at 12-weeks.
Phase: PHASE4 • Sponsor: WW International Inc • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Gene therapy for rare brain diseases: 5-Year safety check begins
Disease control OngoingThis study is to continue Long-Term Follow-Up of Patients who were previously treated with AXO-AAV-GM2 Gene Therapy as treatment for Tay-Sachs or Sandhoff Disease to follow the subjects through 5 years after their initial gene therapy treatment.
Sponsor: Terence Flotte • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Could a common diabetes drug help adult heart defect patients?
Disease control Recruiting nowThe goal of the study is to investigate the feasibility and benefit of novel guideline-directed heart failure therapy drug Empagliflozin (Jardiance) for adult patients with congenital heart disease (ACHD).
Phase: PHASE4 • Sponsor: Anita Saraf • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New drug could reduce need for infusions in nerve disorder
Disease control Recruiting nowThe purpose of this Phase 2 study is to evaluate the safety, tolerability, pharmacometrics, and efficacy of Claseprubart (DNTH103) in participants with multifocal motor neuropathy (MMN).
Phase: PHASE2 • Sponsor: Dianthus Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Nasal spray aims to calm social anxiety fast in public speaking situations
Symptom relief OngoingThis U.S. Phase 3 clinical trial is designed to evaluate the efficacy, safety, and tolerability of the acute intranasal (i.n.) administration of Fasedienol Nasal Spray (fasedienol) (3.2 µg) to relieve symptoms of acute anxiety in adult subjects ages 18 through 65 with Social Anxi…
Phase: PHASE3 • Sponsor: VistaGen Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Could a simple oxygen mask halt rare childhood paralysis attacks?
Symptom relief CompletedAlternating hemiplegia of childhood (AHC) is a rare early-onset neurodevelopmental encephalopathy frequently caused by mutations in the ATP1A3 gene. It is typically characterized by a variable degree of intellectual disability, motor dysfunction and various paroxysmal events (dys…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Can metformin or hydroxyurea cut transfusions for thalassemia patients?
Disease control CompletedThis clinical trial aims to evaluate and compare the effects and safety of hydroxyurea and metformin in transfusion-dependent beta-thalassemia major and correlate responders/non-responders with the single nucleotide polymorphism mutations (SNPs) by DNA analysis. The main questio…
Phase: PHASE4 • Sponsor: Bahria University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Could less chemo be better for older breast cancer patients?
Disease control Recruiting nowThis phase II trial tests how well dose-reduced docetaxel combined with cyclophosphamide works in treating older women with early stage (stage I-III) HER2 negative breast cancer vulnerable to toxicity. Chemotherapy drugs, such as docetaxel and cyclophosphamide, work in different …
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Talking it out: nurse and peer team up to fight postpartum depression
Symptom relief OngoingThe purpose of this study is to determine the effectiveness of an online 9-week group Cognitive Behavioural Therapy (CBT; a type of talking therapy) intervention that is co-led by public health nurses (PHNs) and individuals who have previously recovered (i.e., lay peers) from pos…
Phase: NA • Sponsor: McMaster University • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Brain Scan-Guided therapy could boost depression recovery
Symptom relief Recruiting nowIn this triple-blind randomized controlled trial, we ask if targeting intermittent theta burst stimulation (iTBS) based on individual resting state connectivity improves treatment outcomes in major depressive disorder (MDD). For the trial, we will recruit 210 patients with major …
Phase: NA • Sponsor: The Royal Ottawa Mental Health Centre • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New combo therapy targets Tough-to-Treat myeloma
Disease control OngoingThe purpose of this study is to define the safety of Ciltacabtagene Autoleucel (Cilta-cel) and Talquetamab in participants with high-risk multiple myeloma (MM).
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could prebiotic snacks boost melanoma treatment?
Disease control Recruiting nowTo Determine the feasibility, compliance and adherence to PreFED intervention in resectable melanoma patients initiating neoadjuvant Ipi/Nivo.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
50,000 patients join mega biobank to mine hidden clues in CT and MRI scans
Knowledge-focused Recruiting nowImaging methods today represent the pillar of prevention, diagnosis, patients monitoring and treatment. Improvement in technology led the development of increasingly high-performance scanners whose potential has not yet been fully explored. In particular, recently introduced phot…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Simple breathing workout may cut lung risks after liver surgery
Prevention Recruiting now* Background: Postoperative pulmonary complications (PPCs) are the most common complications after major upper abdominal surgery. PPCs include respiratory infections, severe atelectasis, pleural effusion, bronchospasm, aspiration pneumonitis, pneumothorax, exacerbation of chronic…
Phase: NA • Sponsor: Oulu University Hospital • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC
-
New digital program aims to boost quality of life for colorectal cancer survivors
Symptom relief Recruiting nowOver the last decades, the 3-year recurrence rates for patients with stage I and II colorectal cancer have decreased to just 5% and 12%. The follow-up program offered to stage I and low-risk stage II patients has not changed accordingly and is still focused solely on recurrence d…
Phase: NA • Sponsor: University of Aarhus • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Could a common diabetes drug help transplanted kidneys survive longer?
Disease control OngoingThis randomized, open-label, single-center clinical trial aims to evaluate the effect of dapagliflozin on kidney allograft function in adult recipients of a first living-donor kidney transplant. Participants will be randomized to receive dapagliflozin 10 mg daily starting 4 weeks…
Phase: PHASE2 • Sponsor: University of Guadalajara • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Immune reset: CAR-T cells take on lupus and more
Disease control Recruiting nowThis is an open clinical pharmacological translational Research Study, aiming to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of CD19 or CD19-BCMA CAR-T in patients with active SLE, SSc, AAV, IIM and pSS.
Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New shot could loosen stiff arms after stroke
Symptom relief Recruiting nowThis is a randomized, double-blind, multi-center phase II/III study to evaluate the efficacy and safety of Recombinant Botulinum Toxin Type A (YY001) for injection in the treatment of upper limb spasticity in adults
Phase: PHASE2, PHASE3 • Sponsor: Chongqing Claruvis Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Can a smartphone app bridge the lupus care gap for women of color?
Disease control Recruiting nowThe investigators will test the hypothesis that culturally congruent coaching delivered via a technology application (Health360x) will improve the persistent disparities observed among women of color with lupus or lupus nephritis by addressing underlying psychosocial barriers to …
Phase: NA • Sponsor: Morehouse School of Medicine • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New glasses could slow kids' worsening eyesight
Disease control OngoingThe goal of this clinical trial is to learn if spectacle lenses using Phase Alteration Utilising Sub Elements (P.A.U.S.E.®) technology works to slow down the rate of myopia progression in myopic children. The first stage of the trial compares P.A.U.S.E.® spectacle lenses to singl…
Phase: NA • Sponsor: nthalmic Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC